Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: Further evidence in decompensation cirrhosis-Reference-Cited by-同舟云学术

Efficacy of interferon-based antiviral therapy on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: Further evidence in decompensation cirrhosis

Published:2013-06 Issue:6 Volume:58 Page:1262-1264
ISSN:0168-8278
Container-title:Journal of Hepatology
language:en
Short-container-title:Journal of Hepatology

Author:

Ji Fanpu,Zhang Shu,Deng Hong,Li Zongfang

Publisher

Elsevier BV

Subject

Hepatology

Reference10 articles.

1. Efficacy of pegylated interferon alpha-2b and ribavirin treatment on the risk of hepatocellular carcinoma of patients with chronic hepatitis C: a prospective, multicenter study;Ogawa;J Hepatol,2013

2. Peginterferon alfa-2b and ribavirin in patients with hepatitis C virus and decompensated cirrhosis: a controlled study;Iacobellis;J Hepatol,2007

3. Short-term efficacy and safety of standard interferon with a low accelerating dosage regimen in HCV-related decompensated cirrhosis;Ji;Zhonghua Gan Zang Bing Za Zhi,2010

4. EASL clinical practice guidelines: management of hepatitis C virus infection;European Association for the Study of the Liver;J Hepatol,2011

5. Antiviral therapy for cirrhotic hepatitis C: association with reduced hepatocellular carcinoma development and improved survival;Shiratori;Ann Intern Med,2005

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antiviral Therapy for Hepatitis C Virus Infection in Cirrhosis;Pharmacotherapy for Liver Cirrhosis and Its Complications;2022

2. Spleen-Associated Effects on Immunity in Hepatitis B Virus-Related Cirrhosis with Portal Hypertension;Journal of Interferon & Cytokine Research;2019-02

3. Individual surveillance using model-based hepatocellular carcinoma risk estimates in chronic hepatitis C patients after antiviral treatment;Journal of Hepatology;2019-01

4. Outcomes after sofosbuvir-containing regimens for hepatitis C virus in patients with decompensated cirrhosis: a real-world study;Infectious Agents and Cancer;2017-09-13

5. High Post-treatment α-Fetoprotein Levels and Aspartate Aminotransferase-to-Platelet Ratio Index Predict Hepatocellular Carcinoma in Hepatitis C Virus Decompensated Cirrhotic Patients with Sustained Virological Response After Antiviral Therapy;Journal of Interferon & Cytokine Research;2017-08